Trending
- Longitudinal changes in DNA methylation in IDH-mutant glioma fuel disease progression through altered cell state differentiation
- When to Consider Systemic Therapy for cSCC
- EC Approves Encorafenib/Cetuximab/FOLFOX in 1L BRAF V600E–Mutant mCRC
- The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
- Binimetinib Tablets Receive Tentative FDA Approval in Melanoma/NSCLC
- Data science: new data strategy hails exciting future – Cancer Research UK
- Rewiring the life sciences: why foundations come first for AI in science – Cancer Research UK
- Rovadicitinib, a first-in-class JAK/ROCK inhibitor, in patients with myelofibrosis: a preclinical and phase I study
Monday, June 22